Global and Japan Pediatric Medicines Market Insights, Forecast to 2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 148
Inquire Before Buying

Pediatric Medicines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Pediatric Medicines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Enteral

- Parenteral

- Topical

Segment by Application

- Hospital

- Clinic

- Family

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- Novartis

- Pfizer

- Sanofi

- Abbott

- Bristol-Myers Squibb

- Cipla

- Eisai Pharmaceuticals

- Eli Lilly

- F. Hoffman-La Roche

- Glenmark

- Helsinn Healthcare

- Heron Therapeutics

- Ipca Laboratories

Global and Japan Pediatric Medicines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Pediatric Medicines Product Introduction
1.2 Market by Type
1.2.1 Global Pediatric Medicines Market Size Growth Rate by Type
1.2.2 Enteral
1.2.3 Parenteral
1.2.4 Topical
1.3 Market by Application
1.3.1 Global Pediatric Medicines Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Family
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pediatric Medicines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Medicines Revenue 2016-2027
2.1.2 Global Pediatric Medicines Sales 2016-2027
2.2 Global Pediatric Medicines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pediatric Medicines Historical Market Size by Region (2016-2021)
2.3.1 Global Pediatric Medicines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pediatric Medicines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pediatric Medicines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pediatric Medicines Sales Forecast by Region (2022-2027)
2.4.2 Global Pediatric Medicines Revenue Forecast by Region (2022-2027)
3 Global Pediatric Medicines Competitor Landscape by Players
3.1 Global Top Pediatric Medicines Manufacturers by Sales
3.1.1 Global Pediatric Medicines Sales by Manufacturer (2016-2021)
3.1.2 Global Pediatric Medicines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pediatric Medicines Manufacturers by Revenue
3.2.1 Key Pediatric Medicines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pediatric Medicines Revenue by Manufacturers (2016-2021)
3.2.3 Global Pediatric Medicines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pediatric Medicines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pediatric Medicines Revenue in 2020
3.2.6 Global Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pediatric Medicines Price by Manufacturers
3.4 Global Pediatric Medicines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pediatric Medicines Market Size by Type (2016-2021)
4.1.1 Global Pediatric Medicines Sales by Type (2016-2021)
4.1.2 Global Pediatric Medicines Revenue by Type (2016-2021)
4.1.3 Pediatric Medicines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pediatric Medicines Market Size Forecast by Type (2022-2027)
4.2.1 Global Pediatric Medicines Sales Forecast by Type (2022-2027)
4.2.2 Global Pediatric Medicines Revenue Forecast by Type (2022-2027)
4.2.3 Pediatric Medicines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pediatric Medicines Market Size by Application (2016-2021)
5.1.1 Global Pediatric Medicines Sales by Application (2016-2021)
5.1.2 Global Pediatric Medicines Revenue by Application (2016-2021)
5.1.3 Pediatric Medicines Price by Application (2016-2021)
5.2 Pediatric Medicines Market Size Forecast by Application (2022-2027)
5.2.1 Global Pediatric Medicines Sales Forecast by Application (2022-2027)
5.2.2 Global Pediatric Medicines Revenue Forecast by Application (2022-2027)
5.2.3 Global Pediatric Medicines Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Pediatric Medicines Market Size YoY Growth 2016-2027
6.1.1 Japan Pediatric Medicines Sales YoY Growth 2016-2027
6.1.2 Japan Pediatric Medicines Revenue YoY Growth 2016-2027
6.1.3 Japan Pediatric Medicines Market Share in Global Market 2016-2027
6.2 Japan Pediatric Medicines Market Size by Players (International and Local Players)
6.2.1 Japan Top Pediatric Medicines Players by Sales (2016-2021)
6.2.2 Japan Top Pediatric Medicines Players by Revenue (2016-2021)
6.3 Japan Pediatric Medicines Historic Market Review by Type (2016-2021)
6.3.1 Japan Pediatric Medicines Sales Market Share by Type (2016-2021)
6.3.2 Japan Pediatric Medicines Revenue Market Share by Type (2016-2021)
6.3.3 Japan Pediatric Medicines Price by Type (2016-2021)
6.4 Japan Pediatric Medicines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Pediatric Medicines Sales Forecast by Type (2022-2027)
6.4.2 Japan Pediatric Medicines Revenue Forecast by Type (2022-2027)
6.4.3 Japan Pediatric Medicines Price Forecast by Type (2022-2027)
6.5 Japan Pediatric Medicines Historic Market Review by Application (2016-2021)
6.5.1 Japan Pediatric Medicines Sales Market Share by Application (2016-2021)
6.5.2 Japan Pediatric Medicines Revenue Market Share by Application (2016-2021)
6.5.3 Japan Pediatric Medicines Price by Application (2016-2021)
6.6 Japan Pediatric Medicines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Pediatric Medicines Sales Forecast by Application (2022-2027)
6.6.2 Japan Pediatric Medicines Revenue Forecast by Application (2022-2027)
6.6.3 Japan Pediatric Medicines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pediatric Medicines Market Size YoY Growth 2016-2027
7.2 North America Pediatric Medicines Market Facts & Figures by Country
7.2.1 North America Pediatric Medicines Sales by Country (2016-2021)
7.2.2 North America Pediatric Medicines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pediatric Medicines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pediatric Medicines Market Facts & Figures by Region
8.2.1 Asia Pacific Pediatric Medicines Sales by Region (2016-2021)
8.2.2 Asia Pacific Pediatric Medicines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Pediatric Medicines Market Size YoY Growth 2016-2027
9.2 Europe Pediatric Medicines Market Facts & Figures by Country
9.2.1 Europe Pediatric Medicines Sales by Country (2016-2021)
9.2.2 Europe Pediatric Medicines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pediatric Medicines Market Size YoY Growth 2016-2027
10.2 Latin America Pediatric Medicines Market Facts & Figures by Country
10.2.1 Latin America Pediatric Medicines Sales by Country (2016-2021)
10.2.2 Latin America Pediatric Medicines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pediatric Medicines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pediatric Medicines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pediatric Medicines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pediatric Medicines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Pediatric Medicines Products Offered
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Pediatric Medicines Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Pediatric Medicines Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Pediatric Medicines Products Offered
12.4.5 Sanofi Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Description and Business Overview
12.5.3 Abbott Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Pediatric Medicines Products Offered
12.5.5 Abbott Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Pediatric Medicines Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Cipla
12.7.1 Cipla Corporation Information
12.7.2 Cipla Description and Business Overview
12.7.3 Cipla Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cipla Pediatric Medicines Products Offered
12.7.5 Cipla Recent Development
12.8 Eisai Pharmaceuticals
12.8.1 Eisai Pharmaceuticals Corporation Information
12.8.2 Eisai Pharmaceuticals Description and Business Overview
12.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eisai Pharmaceuticals Pediatric Medicines Products Offered
12.8.5 Eisai Pharmaceuticals Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Pediatric Medicines Products Offered
12.9.5 Eli Lilly Recent Development
12.10 F. Hoffman-La Roche
12.10.1 F. Hoffman-La Roche Corporation Information
12.10.2 F. Hoffman-La Roche Description and Business Overview
12.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 F. Hoffman-La Roche Pediatric Medicines Products Offered
12.10.5 F. Hoffman-La Roche Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Pediatric Medicines Products Offered
12.11.5 GSK Recent Development
12.12 Helsinn Healthcare
12.12.1 Helsinn Healthcare Corporation Information
12.12.2 Helsinn Healthcare Description and Business Overview
12.12.3 Helsinn Healthcare Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Helsinn Healthcare Products Offered
12.12.5 Helsinn Healthcare Recent Development
12.13 Heron Therapeutics
12.13.1 Heron Therapeutics Corporation Information
12.13.2 Heron Therapeutics Description and Business Overview
12.13.3 Heron Therapeutics Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Heron Therapeutics Products Offered
12.13.5 Heron Therapeutics Recent Development
12.14 Ipca Laboratories
12.14.1 Ipca Laboratories Corporation Information
12.14.2 Ipca Laboratories Description and Business Overview
12.14.3 Ipca Laboratories Pediatric Medicines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Ipca Laboratories Products Offered
12.14.5 Ipca Laboratories Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pediatric Medicines Industry Trends
13.2 Pediatric Medicines Market Drivers
13.3 Pediatric Medicines Market Challenges
13.4 Pediatric Medicines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Pediatric Medicines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Enteral
Table 3. Major Manufacturers of Parenteral
Table 4. Major Manufacturers of Topical
Table 5. Global Pediatric Medicines Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Pediatric Medicines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Pediatric Medicines Sales by Regions (2016-2021) & (K Units)
Table 8. Global Pediatric Medicines Sales Market Share by Regions (2016-2021)
Table 9. Global Pediatric Medicines Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Pediatric Medicines Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Pediatric Medicines Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Pediatric Medicines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Pediatric Medicines Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Pediatric Medicines Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Pediatric Medicines Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Pediatric Medicines Manufacturers by Revenue (US$ Million) in 2020
Table 17. Pediatric Medicines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Pediatric Medicines Revenue Share by Manufacturers (2016-2021)
Table 19. Global Pediatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Pediatric Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Medicines as of 2020)
Table 21. Key Manufacturers Pediatric Medicines Price (2016-2021) (USD/Unit)
Table 22. Pediatric Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pediatric Medicines Product Type
Table 24. Date of International Manufacturers Enter into Pediatric Medicines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Medicines Sales by Type (2016-2021) (K Units)
Table 27. Global Pediatric Medicines Sales Share by Type (2016-2021)
Table 28. Global Pediatric Medicines Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Pediatric Medicines Revenue Share by Type (2016-2021)
Table 30. Pediatric Medicines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Pediatric Medicines Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Pediatric Medicines Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Pediatric Medicines Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Pediatric Medicines Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Pediatric Medicines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Pediatric Medicines Sales by Application (2016-2021) (K Units)
Table 37. Global Pediatric Medicines Sales Share by Application (2016-2021)
Table 38. Global Pediatric Medicines Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Pediatric Medicines Revenue Share by Application (2016-2021)
Table 40. Pediatric Medicines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Pediatric Medicines Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Pediatric Medicines Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Pediatric Medicines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Pediatric Medicines Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Pediatric Medicines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. Japan Pediatric Medicines Sales (K Units) of Key Companies (2016-2021)
Table 47. Japan Pediatric Medicines Sales Share by Company (2016-2021)
Table 48. Japan Pediatric Medicines Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Pediatric Medicines Revenue Share by Company (2016-2021)
Table 50. Japan Pediatric Medicines Sales (K Units) by Type (2016-2021)
Table 51. Japan Pediatric Medicines Sales Share by Type (2016-2021)
Table 52. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Pediatric Medicines Price (USD/Unit) by Type (2016-2021)
Table 54. Japan Pediatric Medicines Sales (K Units) by Type (2022-2027)
Table 55. Japan Pediatric Medicines Sales Share by Type (2022-2027)
Table 56. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Pediatric Medicines Revenue Share by Type (2022-2027)
Table 58. Japan Pediatric Medicines Price (USD/Unit) by Type (2022-2027)
Table 59. Japan Pediatric Medicines Sales (K Units) by Application (2016-2021)
Table 60. Japan Pediatric Medicines Sales Share by Application (2016-2021)
Table 61. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Pediatric Medicines Price (USD/Unit) by Application (2016-2021)
Table 63. Japan Pediatric Medicines Sales (K Units) by Application (2022-2027)
Table 64. Japan Pediatric Medicines Sales Share by Application (2022-2027)
Table 65. Japan Pediatric Medicines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Pediatric Medicines Revenue Share by Application (2022-2027)
Table 67. Japan Pediatric Medicines Price (USD/Unit) by Application (2022-2027)
Table 68. North America Pediatric Medicines Sales by Country (2016-2021) & (K Units)
Table 69. North America Pediatric Medicines Sales Market Share by Country (2016-2021)
Table 70. North America Pediatric Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Pediatric Medicines Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Pediatric Medicines Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Pediatric Medicines Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Pediatric Medicines Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Pediatric Medicines Revenue Market Share by Region (2016-2021)
Table 76. Europe Pediatric Medicines Sales by Country (2016-2021) & (K Units)
Table 77. Europe Pediatric Medicines Sales Market Share by Country (2016-2021)
Table 78. Europe Pediatric Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Pediatric Medicines Revenue Market Share by Country (2016-2021)
Table 80. Latin America Pediatric Medicines Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Pediatric Medicines Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Pediatric Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Pediatric Medicines Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Pediatric Medicines Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Pediatric Medicines Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Pediatric Medicines Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Pediatric Medicines Revenue Market Share by Country (2016-2021)
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GSK Pediatric Medicines Product
Table 92. GSK Recent Development
Table 93. Novartis Corporation Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Novartis Product
Table 97. Novartis Recent Development
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Pfizer Product
Table 102. Pfizer Recent Development
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Business Overview
Table 105. Sanofi Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Sanofi Product
Table 107. Sanofi Recent Development
Table 108. Abbott Corporation Information
Table 109. Abbott Description and Business Overview
Table 110. Abbott Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Abbott Product
Table 112. Abbott Recent Development
Table 113. Bristol-Myers Squibb Corporation Information
Table 114. Bristol-Myers Squibb Description and Business Overview
Table 115. Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Cipla Corporation Information
Table 119. Cipla Description and Business Overview
Table 120. Cipla Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Cipla Product
Table 122. Cipla Recent Development
Table 123. Eisai Pharmaceuticals Corporation Information
Table 124. Eisai Pharmaceuticals Description and Business Overview
Table 125. Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Eisai Pharmaceuticals Product
Table 127. Eisai Pharmaceuticals Recent Development
Table 128. Eli Lilly Corporation Information
Table 129. Eli Lilly Description and Business Overview
Table 130. Eli Lilly Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Eli Lilly Product
Table 132. Eli Lilly Recent Development
Table 133. F. Hoffman-La Roche Corporation Information
Table 134. F. Hoffman-La Roche Description and Business Overview
Table 135. F. Hoffman-La Roche Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. F. Hoffman-La Roche Product
Table 137. F. Hoffman-La Roche Recent Development
Table 138. Glenmark Corporation Information
Table 139. Glenmark Description and Business Overview
Table 140. Glenmark Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Glenmark Product
Table 142. Glenmark Recent Development
Table 143. Helsinn Healthcare Corporation Information
Table 144. Helsinn Healthcare Description and Business Overview
Table 145. Helsinn Healthcare Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Helsinn Healthcare Product
Table 147. Helsinn Healthcare Recent Development
Table 148. Heron Therapeutics Corporation Information
Table 149. Heron Therapeutics Description and Business Overview
Table 150. Heron Therapeutics Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Heron Therapeutics Product
Table 152. Heron Therapeutics Recent Development
Table 153. Ipca Laboratories Corporation Information
Table 154. Ipca Laboratories Description and Business Overview
Table 155. Ipca Laboratories Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Ipca Laboratories Product
Table 157. Ipca Laboratories Recent Development
Table 158. Pediatric Medicines Market Trends
Table 159. Pediatric Medicines Market Drivers
Table 160. Pediatric Medicines Market Challenges
Table 161. Pediatric Medicines Market Restraints
Table 162. Pediatric Medicines Customers List
Table 163. Pediatric Medicines Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Medicines Product Picture
Figure 2. Global Pediatric Medicines Sales Market Share by Type in 2020 & 2027
Figure 3. Enteral Product Picture
Figure 4. Parenteral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Pediatric Medicines Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Family
Figure 10. Pediatric Medicines Report Years Considered
Figure 11. Global Pediatric Medicines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pediatric Medicines Market Size 2016-2027 (US$ Million)
Figure 13. Global Pediatric Medicines Sales 2016-2027 (K Units)
Figure 14. Global Pediatric Medicines Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Pediatric Medicines Sales Market Share by Region (2016-2021)
Figure 16. Global Pediatric Medicines Sales Market Share by Region in 2020
Figure 17. Global Pediatric Medicines Revenue Market Share by Region (2016-2021)
Figure 18. Global Pediatric Medicines Revenue Market Share by Region in 2020
Figure 19. Global Pediatric Medicines Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Medicines Revenue in 2020
Figure 21. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Pediatric Medicines Sales Market Share by Type (2016-2021)
Figure 23. Global Pediatric Medicines Sales Market Share by Type in 2020
Figure 24. Global Pediatric Medicines Revenue Market Share by Type (2016-2021)
Figure 25. Global Pediatric Medicines Revenue Market Share by Type in 2020
Figure 26. Global Pediatric Medicines Sales Market Share by Application (2016-2021)
Figure 27. Global Pediatric Medicines Sales Market Share by Application in 2020
Figure 28. Global Pediatric Medicines Revenue Market Share by Application (2016-2021)
Figure 29. Global Pediatric Medicines Revenue Market Share by Application in 2020
Figure 30. Japan Pediatric Medicines Sales Growth Rate 2016-2027 (K Units)
Figure 31. Japan Pediatric Medicines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Pediatric Medicines Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Pediatric Medicines Players Market Share by Revenue in Pediatric Medicines in 2020
Figure 34. Japan Pediatric Medicines Revenue Share by Type (2016-2021)
Figure 35. Japan Pediatric Medicines Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Pediatric Medicines Revenue Share by Application (2016-2021)
Figure 37. Japan Pediatric Medicines Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Pediatric Medicines Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Pediatric Medicines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Pediatric Medicines Sales Market Share by Country in 2020
Figure 41. North America Pediatric Medicines Revenue Market Share by Country in 2020
Figure 42. U.S. Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Pediatric Medicines Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Pediatric Medicines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Pediatric Medicines Sales Market Share by Country in 2020
Figure 49. Europe Pediatric Medicines Revenue Market Share by Country in 2020
Figure 50. Germany Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Pediatric Medicines Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Pediatric Medicines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Pediatric Medicines Sales Market Share by Region in 2020
Figure 63. Asia Pacific Pediatric Medicines Revenue Market Share by Region in 2020
Figure 64. China Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Pediatric Medicines Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Pediatric Medicines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Pediatric Medicines Sales Growth Rate (2016-2021)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs